The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Hopefully a photograph of the machine equipment that was in the box’s working at full tilt...
Oh dear,
I think share price is rising again
Bosi,
That’s hell of a find .... Hats of to you .
However SNG 001 can be approved first and has an effective rate of 79% this would be considered an excellent result and would be approved. Not many drugs have a effectiveness ratio of greater than 80%. In report [ ] the mortality rate is 24.6% of the number of patients admitted to hospital with COVID -19. This is an extremely high mortality rate. SNG 001 is approved the mortality rate would reduce this to 5.1%.
If SNG001 is approved before Oxford Vaccine it would be possible to use SNG001 as the treatment. If Oxford Vaccine was proved safe it could then be issued at risk as SNG was close to authorisation saving a lot of time distributing the vaccine when approved.
The type A viruses are the most virulent human pathogens among the three influenza types and cause the most severe disease. The serotypes that have been confirmed in humans, ordered by the number of known human pandemic deaths, are:
H1N1 caused "Spanish flu" in 1918 and "Swine flu" in 2009.[30]
H2N2 caused "Asian Flu".
H3N2 caused "Hong Kong Flu".
H5N1, "avian" or "bird flu".[31]
H7N7 has unusual zoonotic potential.[32]
H1N2 is endemic in humans and pigs[citation needed].
H9N2, H7N2, H7N3, H10N7.
Known flu pandemics[10][33][34]
Name of pandemic Date Deaths Case fatality rate Subtype involved Pandemic Severity Index
1889–1890 flu pandemic
(Asiatic or Russian Flu)[35] 1889–1890 1 million 0.15% possibly H3N8
or H2N2 N/A
1918 flu pandemic
(Spanish flu)[36] 1918–1920 20 to 100 million 2% H1N1 5
Asian Flu 1957–1958 1 to 1.5 million 0.13% H2N2 2
Hong Kong Flu 1968–1969 0.75 to 1 million <0.1% H3N2 2
Russian flu 1977–1978 no accurate count N/A H1N1 N/A
2009 flu pandemic[37][38] 2009–2010 105,700–395,600[39] 0.03% H1N1 N/A
Influenza B
Feeds,
I think you will find the Spanish flu was a coronavirus we just didn’t have the technology back in 1918 to identify viruses at that level. I’ve supplied an easy to find link to confirm the common cold and flu are coronavirus.
Your comments form earlier.
My thinking is that flu virus' usually have a second peak, but this virus is different.
Anyway I may be dumb and ill informed but personally I think comparing the 1918 Spanish flu to Covid19 is wrong, because they were different viruses.
https://www.google.co.uk/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjHwMPY7-brAhVRtXEKHb2MATIQFjAUegQIBxAB&url=https%3A%2F%2Fwww.niaid.nih.gov%2Fdiseases-conditions%2Fcoronaviruses&usg=AOvVaw2X64Q0NRO99apev2hXDpXp
Reported cases of Spanish flu dropped off over the summer of 1918, and there was hope at the beginning of August that the virus had run its course. In retrospect, it was only the calm before the storm. Somewhere in Europe, a mutated strain of the Spanish flu virus had emerged that had the power to kill a perfectly healthy young man or woman within 24 hours of showing the first signs of infection.
I have said since I have joined this forum that I don't think there will be a second wave, and I've been called a complete muppet for it (not that I care).
In late August 1918, military ships departed the English port city of Plymouth carrying troops unknowingly infected with this new, far deadlier strain of Spanish flu. As these ships arrived in cities like Brest in France, Boston in the United States and Freetown in west Africa, the second wave of the global pandemic began.
History says you will be proven incorrect
MB,
Mentioned he didn’t do twitter. I will take that at face value. But don’t believe twitter is the driving force behind this investment. Thanks
gKb47,
I read your post and plagiarism can be seen as a complement
Folks,
Just read an article where a WHO source suggested that production capacity in the UK would not meet a fraction of the required capacity for the UK alone.
I really struggle to believe the ODX and it’s backers are not seriously considering increasing production capacity by many multiples given the huge and unprecedented opportunity that we are looking at here.
Given the UK is medium sized country the global demand for these tests will be profound - it would honestly not be a stretch to imagine this share price ending up at many many multiples from where we are now.
In the spirit of challenging confirmation bias I wondered what everyone else thought about the scale of the opportunity and the timing of a scale up.
Seems to me this is an almost once in a century business opportunity. A brand new product with essentially unlimited demand.
What am I missing?
Lot’s
What am I missing?
Possibly reading all Company RNS Releases . Proactive interview interviews and generally doing a little bit of research on top of that.
WHO knows what other investments you could come across. Oh and these billboards are full of useful and useless information. But I think you know that already.
Good Evening Folks
The inverse of this is anybody who tests negative for antigen, then also negative for antibodies is almost certainly virus free and can be given a digital health certificate and allowed to return to work until their next tests."
Not really. The testing can only indicate that the subject is virus free at the point the test is performed. To suggest that this virus-free status endures "until their next tests" is a stretch too far. To be clear, it is possible that someone who tests negative might be infected by the next person they meet.
In practice this just means that more (endless...) tests will be required."
Correct.
More tests more orders .
And as a foot note they eventually mentioned ODC
Omega Diagnostics partner Mologic was one of three rapid COVID-19 tests being trialled by Heathrow recently.
Another report claims that this test was launched today following a three-week trial at Heathrow airport. However this report via the Evening Express suggests it may not be the done deal that the FT is indicating – noting it is ‘about to embark on clinical trials’ to be certified for medical use.
Heathrow airport has reportedly .
Yes reportedly
Heathrow airport has reportedly selected a saliva-based COVID-19 test from British tech start-up iAbra which can return results within 20 seconds as it seeks to get people flying safely.
The Financial Times claims !!
This test encompasses a computer to scan for the virus which costs $20,000 and each test kit is around the price of a ‘paperback book’.
Interesting but expensive. Thanks for posting the information .
Oh sharebuyers.
Brilliant they know best . Thanks (Not)